1
|
Fox HC, Milivojevic V, MacDougall A, LaVallee H, Simpson C, Angarita GA, Sinha R. Stress-related suppression of peripheral cytokines predicts future relapse in alcohol-dependent individuals with and without subclinical depression. Addict Biol 2020; 25:e12832. [PMID: 31736187 DOI: 10.1111/adb.12832] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2019] [Revised: 07/22/2019] [Accepted: 08/28/2019] [Indexed: 12/01/2022]
Abstract
Chronic alcohol abuse and depressive symptoms are both associated with peripheral cytokine changes. Despite this, cytokine adaptations have not been assessed in co-morbid populations or prospectively as predictors of relapse. We examine cytokine responses to stress in alcohol-dependent individuals and social drinkers, both with and without subclinical depression. We also examine the potential link between cytokine adaptations in response to stress and prospective alcohol relapse risk. Thirty-three, alcohol-dependent individuals (21 with and 12 without high depressive symptoms) and 37 controls (16 with and 21 without high depressive symptoms) were exposed to two 5-minute personalized guided imagery conditions (stress and neutral) across consecutive days in a randomized and counterbalanced order. Alcohol craving and serum measures of tumor necrosis factor alpha (TNFα), tumor necrosis factor receptor 1 (TNFR1), interleukin-6 (IL-6), and interleukin-1 receptor antagonist (IL-1ra) were collected prior to and following imagery exposure. Following treatment discharge, follow-up interviews were conducted over 90 days to assess relapse. Dampened IL-1ra and IL-6 in response to stress was observed as a function of alcohol dependence and not moderated by depressive symptoms. Lower levels of IL-6 following stress also predicted greater drinking days following treatment. Conversely, high depressive symptomatology was associated solely with pro-inflammatory adaptations. Stress-related suppression of TNFα predicted drinking severity only in alcohol-dependent individuals with subclinical depression, and suppressed TNFR1 following stress was only seen in individuals with subclinical depression. Stress-induced suppression of pro-inflammatory TNF markers may indicate a risk factor for alcohol-dependent individuals with co-occurring depressive symptoms.
Collapse
Affiliation(s)
- Helen C. Fox
- Department of Psychiatry, School of Medicine Stony Brook University Stony Brook NY USA
| | - Verica Milivojevic
- The Yale Stress Center, Department of Psychiatry Yale University School of Medicine New Haven CT USA
| | - Alicia MacDougall
- The Yale Stress Center, Department of Psychiatry Yale University School of Medicine New Haven CT USA
| | - Heather LaVallee
- The Yale Stress Center, Department of Psychiatry Yale University School of Medicine New Haven CT USA
| | - Christine Simpson
- Department of Internal Medicine Yale University School of Medicine New Haven CT USA
| | - Gustavo A. Angarita
- Clinical Neuroscience Research Unit, The Connecticut Mental Health Center, Department of Psychiatry Yale University School of Medicine New Haven CT USA
| | - Rajita Sinha
- The Yale Stress Center, Department of Psychiatry Yale University School of Medicine New Haven CT USA
| |
Collapse
|
2
|
Liu J, Zhou C, Tao X, Feng L, Wang X, Chen L, Li C, Huang D, Fang S, Shen Y. ER stress-inducible protein MANF selectively expresses in human spleen. Hum Immunol 2015; 76:823-30. [PMID: 26429332 DOI: 10.1016/j.humimm.2015.09.043] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2013] [Revised: 06/17/2015] [Accepted: 09/26/2015] [Indexed: 11/25/2022]
Abstract
Mesencephalic astrocyte-derived neurotrophic factor (MANF; also known as arginine-rich, mutated in early tumors; ARMET), is an ER stress-inducible protein, and widely expressed in mammalian tissues. In this study, we are interested in the profile of MANF expression in human splenocytes. Three patients with spleen trauma were enrolled in this study. Immunohistochemistry and immunofluorescence were used to detect MANF expression in the four types of cells, including T cells, B cells, plasma cells, and macrophages in spleens by using the specific antibodies of anti-CD3, anti-CD20, anti-CD138, and anti-CD68, respectively. We found that MANF-positive cells extensively distributed in the red pulp and marginal-zone of spleen, and MANF was almost localized in the cytoplasm of splenocytes. Double immunofluorescent staining results showed that MANF localized mainly in the plasma cells and macrophages, but not in T and B cells. Meanwhile, we found that some MANF-positive cells expressed ER stress-related proteins, including ATF6, XBP1s, BiP, and CHOP. These results suggest that the selective expression of MANF in splenocytes may be involved in plasma cell differentiation and immune regulation.
Collapse
Affiliation(s)
- Jun Liu
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; School of Pharmacy, Anhui Medical University, Hefei 230032, China; Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China
| | - Chengyue Zhou
- The 4th Affiliated Hospital of Anhui Medical University, Hefei 230032, China
| | - Xiaofang Tao
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China
| | - Lijie Feng
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China
| | - Xia Wang
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China
| | - Lijian Chen
- The First Affiliated Hospital of Anhui Medical University, Hefei 230032, China
| | - Chengjin Li
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China
| | - Dake Huang
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China
| | - Shengyun Fang
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China
| | - Yuxian Shen
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; Biopharmaceutical Research Institute, Anhui Medical University, Hefei 230032, China.
| |
Collapse
|
3
|
Marathe A, Iyer S, Qiu ZJ, Visich J, Mager DE. Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice. Pharm Res 2012; 29:3180-7. [PMID: 22806404 DOI: 10.1007/s11095-012-0813-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2011] [Accepted: 06/20/2012] [Indexed: 11/24/2022]
Abstract
PURPOSE To characterize the pharmacokinetic (PK) and pharmacodynamic (PD) properties of a monoclonal antibody directed against the B-cell activating factor (BAFF) receptor 3 (BR3), following intravenous (IV) and subcutaneous (SC) administration in mice. METHODS Single IV doses of 0.2, 2.0 and 20 mg/kg and a single SC injection of 20 mg/kg of anti-BR3 antibody was administered to mice. Serum drug and BAFF concentrations and splenic B-cell concentrations were measured at various time points. Pooled PK profiles were described by a two-compartmental model with time-dependent nonlinear elimination, and BAFF profiles were defined by an indirect response model. Fractional receptor occupancy served as the driving function for a competitive reversible antagonism model to characterize B-cell dynamics. RESULTS Noncompartmental analysis revealed a decrease in drug clearance (31.3 to 7.93 mL/day/kg) with increasing IV doses. The SC dose exhibited slow absorption (T(max) = 2 days) and complete bioavailability. All doses resulted in a dose-dependent increase in BAFF concentrations and decrease in B-cell counts. The proposed model reasonably captured complex PK/PD profiles of anti-BR3 antibody after IV and SC administration. CONCLUSIONS A mechanistic model was developed that describes the reversible competition between anti-BR3 antibody and BAFF for BR3 receptors and its influence on B-cell pharmacodynamics.
Collapse
Affiliation(s)
- Anshu Marathe
- Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, 431 Kapoor Hall, Buffalo, New York 14214, USA
| | | | | | | | | |
Collapse
|
4
|
Muhammad K, Roll P, Einsele H, Dörner T, Tony HP. Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatment. ACTA ACUST UNITED AC 2009; 60:2284-93. [DOI: 10.1002/art.24722] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|